INNOCENT or not, seven-time Tour de France champion Lance Armstrong's decision to stop fighting allegations of doping is certainly bad news for athletes looking for better ways to cheat.
Armstrong faced charges, including the use of blood booster EPO and blood transfusions, from the US Anti-Doping Agency (USADA). The agency said it had persuaded several of Armstrong's former teammates to testify against him. That testimony will no longer be heard in public.
Whenever potentially revealing testimony is aired in public, those thinking about doping gain a new resource to draw on, says Graham Arthur, legal director at UK Anti-Doping (UKAD).
The information that the Armstrong witnesses were prepared to reveal will still be used by USADA in its fight against drugs cheats, says Arthur.
- Subscribe to New Scientist and you'll get:
- New Scientist magazine delivered every week
- Unlimited access to all New Scientist online content -
a benefit only available to subscribers - Great savings from the normal price
- Subscribe now!
If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.
Have your say
Only subscribers may leave comments on this article. Please log in.
Only personal subscribers may leave comments on this article
All comments should respect the New Scientist House Rules. If you think a particular comment breaks these rules then please use the "Report" link in that comment to report it to us.
If you are having a technical problem posting a comment, please contact technical support.
0 komentar:
Posting Komentar